Evaluation of retinal toxicity and efficacy of anti-cytomegalovirus and anti-herpes simplex virus antiviral phosphorothioate oligonucleotides ISIS 2922 and ISIS 4015

The Journal of Infectious Diseases
M Flores-AguilarW R Freeman

Abstract

Retinal toxicity of ISIS 2922 and ISIS 4015, phosphorothioate oligonucleotides complementary to human cytomegalovirus (CMV) and herpes simplex virus (HSV) RNA, were evaluated. The intravitreal concentration of ISIS 2922 found not to cause permanent toxic changes in the rabbit retina was 10 microM and in the pig retina, 5 microM. The 3 microM concentration was associated with a transient inflammatory response, and 1 microM caused no retinal toxicity or inflammation. ISIS 4015 showed very mild toxicity with no permanent retinal changes and very mild inflammation at doses of 10 microM; this dose was effective in ameliorating or preventing HSV-1 retinitis when injected 1 day and 1 week prior to virus inoculation. These oligonucleotides have a low intraocular therapeutic index. Attempts to improve the therapeutic index of these compounds are indicated. Only a clinical trial can determine the toxicity profile of ISIS 2922 for the treatment of CMV retinitis.

Citations

Mar 29, 2002·Reviews in Medical Virology·Elke Bogner
May 12, 2000·Biochimica Et Biophysica Acta·N Agarwal, A M Gewirtz
Feb 16, 2000·Progress in Retinal and Eye Research·A BochotE Fattal
Jun 14, 2003·Antisense & Nucleic Acid Drug Development·M BerdugoF Behar-Cohen
Jul 21, 1998·Antisense & Nucleic Acid Drug Development·A D Branch
Jan 11, 2000·Clinical Microbiology Reviews·P LeyssenJ Neyts
Jun 25, 1999·The British Journal of Ophthalmology·W Y ShenP E Rakoczy
Apr 30, 2002·Clinical Pharmacokinetics·Richard S GearyLisa R Grillone
Jun 1, 2012·Expert Opinion on Drug Discovery·Ravinder Malik, Ipsita Roy
Jul 9, 2010·American Journal of Ophthalmology·Peter K KaiserUNKNOWN Sirna-027 Study Investigators
Aug 2, 2002·Biochemical and Biophysical Research Communications·M VoigtF Behar-Cohen
Nov 14, 2006·Advanced Drug Delivery Reviews·Elias Fattal, Amélie Bochot
Nov 26, 1999·Antiviral Chemistry & Chemotherapy·A K Field
Aug 30, 2008·Antiviral Chemistry & Chemotherapy·Hugh J Field, Erik De Clercq
Feb 19, 2002·Laboratory Investigation; a Journal of Technical Methods and Pathology·Wei-Yong ShenP Elizabeth Rakoczy
Aug 12, 1998·Biochemistry·B D PerkinsK M Vasquez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.